R1 RCM Inc. (RCM)
- Previous Close
12.02 - Open
11.92 - Bid 11.91 x 500
- Ask 11.95 x 100
- Day's Range
11.81 - 12.06 - 52 Week Range
8.87 - 18.70 - Volume
1,560,940 - Avg. Volume
3,646,970 - Market Cap (intraday)
5.026B - Beta (5Y Monthly) 0.78
- PE Ratio (TTM)
1,194.50 - EPS (TTM)
0.01 - Earnings Date Feb 14, 2024 - Feb 19, 2024
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
16.93
R1 RCM Inc. provides technology-driven solutions for the financial performance and patient experience of health systems, hospitals, and physician groups. It provides operating partnership/end-to-end solutions, which manages multiple aspects of the revenue cycle to realize financial leverage and revenue improvement for hospital and physician customers. The company also offers modular solutions, including functional partnership, an outsourcing solutions for improvements across targeted revenue cycle areas for hospital and physician group customers; revenue recovery, to fast-track payer and patient cash collections; revenue optimization, a solution to uncover missed or underreported revenue; clinical integrity, used to improve documentation and coding accuracy to maximize earned revenue for the services provided; and regulatory navigation, a compliance-first solutions for government reimbursement accuracy, pharmacy savings, and compliance. The company was incorporated in 2003 and is headquartered in Murray, Utah.
www.r1rcm.com29,400
Full Time Employees
December 31
Fiscal Year Ends
Sector
Industry
Recent News: RCM
Performance Overview: RCM
Trailing total returns as of 4/19/2024, which may include dividends or other distributions. Benchmark is .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: RCM
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: RCM
Valuation Measures
Market Cap
5.06B
Enterprise Value
6.63B
Trailing P/E
1.20k
Forward P/E
77.52
PEG Ratio (5yr expected)
3.10
Price/Sales (ttm)
2.42
Price/Book (mrq)
1.84
Enterprise Value/Revenue
2.94
Enterprise Value/EBITDA
15.55
Financial Highlights
Profitability and Income Statement
Profit Margin
0.15%
Return on Assets (ttm)
3.29%
Return on Equity (ttm)
0.12%
Revenue (ttm)
2.25B
Net Income Avi to Common (ttm)
3.3M
Diluted EPS (ttm)
0.01
Balance Sheet and Cash Flow
Total Cash (mrq)
173.6M
Total Debt/Equity (mrq)
63.26%
Levered Free Cash Flow (ttm)
325.94M
Research Analysis: RCM
Analyst Price Targets
Fair Value
Analyst Recommendations
- Strong Buy
- Buy
- Hold
- Underperform
- Sell
Earnings
Research Reports: RCM
RCM: Rating increased to a HOLD
R1 RCM INC has an Investment Rating of HOLD; a target price of $10.000000; an Industry Subrating of Low; a Management Subrating of Medium; a Safety Subrating of Medium; a Financial Strength Subrating of Medium; a Growth Subrating of Medium; and a Value Subrating of Low.
RatingNeutralPrice TargetRCM: What does Argus have to say about RCM?
R1 RCM INC has an Investment Rating of SELL; a target price of $10.000000; an Industry Subrating of Low; a Management Subrating of Medium; a Safety Subrating of Medium; a Financial Strength Subrating of Medium; a Growth Subrating of Medium; and a Value Subrating of Low.
RatingBearishPrice TargetRCM: What does Argus have to say about RCM?
R1 RCM INC has an Investment Rating of SELL; a target price of $10.000000; an Industry Subrating of Low; a Management Subrating of Medium; a Safety Subrating of Medium; a Financial Strength Subrating of Medium; a Growth Subrating of Medium; and a Value Subrating of Low.
RatingBearishPrice TargetRCM: What does Argus have to say about RCM?
R1 RCM INC has an Investment Rating of SELL; a target price of $10.000000; an Industry Subrating of Low; a Management Subrating of Medium; a Safety Subrating of Medium; a Financial Strength Subrating of Medium; a Growth Subrating of Medium; and a Value Subrating of Low.
RatingBearishPrice Target